• How fast the market of your interest is growing?

    How fast the market of your interest is growing?

    Key drivers behind the growth..

  • What are your biggest Challenges?
    What are your biggest Challenges?
    Identify the key problems..
  • What are your Revenue pockets?
    What are your Revenue pockets?
    Areas you need to bet..
  • What are your Competitors doing?
    What are your Competitors doing?
    Know your competitive edge..
  • Who is your Customer?
    Who is your Customer?
    Get Their changing preferences..
what we offer

Report Store

Healthcare is an ever changing domain with an explosion in knowledge and breakthrough discoveries. Hence, it has become a major thrust area for the global giants in the pharmaceutical, biotechnology and medical devices industries and also for corporates involved in research and development of new products.

IQ4I's focus areas in Healthcare include Pharmaceuticals, biotechnology, Medical devices and Healthcare IT. Since these domains cater to humans, they are subject to stringent regulatory mechanisms requiring highly specialized skills in knowledge processing, with superior quality and adherence to global standards.

IQ4I

Latest Reports

Pharmaceutical excipients are inactive substances in the drug which help in modulating the solubility, bioavailability, and stability of active substances for formulating final drug dosage forms. The excipients form the major part of any medicinal product and the proportion of it, when compared to Active Pharmaceutical Ingredient (API), exceeds two to three folds in any pharmaceutical preparations. Hence, various characteristics such as functionality, regulatory status, sources, cost, consistency, bioavailability, physicochemical properties, stability, pharmacokinetic parameters, etc. play a major role in determining the suitability of a substance as an excipient.
View Details
Each drug is made up of two components that are API and excipients, having curative activity. APIs are often known as bulk pharmaceuticals and most of all APIs are in powder form. Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having a direct effect on disease treatment. APIs are synthesized based on chemical synthesis, fermentation, biotechnological methods or enhanced from the natural source.
View Details
Factors such as the growing patient population with chronic conditions increasing the demand for embolization procedures, and technology advancements are driving the market growth, whereas, acquisitions and collaborations and emerging markets are providing growth opportunities for the embolotherapy market.
View Details
Cell lines are major tools used in research for studying the normal physiology and biochemistry of cells, the effects of drugs and toxic compounds on the cells, drug screening and development and large scale manufacturing of biological compounds. Cell culture is the process by which cells are grown under controlled conditions derived from microbial or animal cells. Cell lines are subculture of primary culture also known as sub-clone. Cell lines derived from primary cultures have a limited life span, after subsequent cultures, cells with the highest growth capacity dominate which are selected for further cell development. Primary cells are cells that are cultured directly from a subject and have a limited lifespan. An immortalized cell line can proliferate indefinitely either through random mutation or deliberate modification which are useful especially for production of therapeutics.
View Details
Biologics are the therapeutic entities composed of sugars, proteins, or nucleic acids and made from natural sources such as human, animal or microorganisms. Biologics also include live attenuated microorganisms (vaccines), allergenic extracts (allergy shots), human cells and tissues (for transplantation), cell and gene therapeutics. Similar to the conventional therapeutics, these drugs help in treating several diseases but are highly specific and more efficient in their disease healing mechanisms. The biologic entities like monoclonal antibodies and recombinant proteins target specific areas during their molecular mechanism of disease curing.
View Details
Surgical sealants, adhesives, and hemostats (SAH) are used to close surgical incisions, post-surgical application, block the passage of fluids through the surface or openings of the wounds, and also to avoid microbial adhesions and infections. Sealants and adhesives are considered together as they both adhere to and seal the surgical incisions, while, hemostats are used to achieve hemostasis when the conventional method is ineffective and impractical.
View Details
The factors such as increasing prevalence of cancer cases, growing adoption of minimally invasive procedures, increasing geriatric population, technological advancements in the field of interventional oncology, and expansion in the emerging markets are driving the market.
View Details
Neuromodulation devices market has huge opportunity for existing players and new entrants, the neuromodulation device manufacturers can develop and launch new products to gain the sparely occupied market.
View Details
Cell analysis is important to understand, predict, and ultimately analyze factors that underlie cell health, proliferation, function, and death by using various technologies such as PCR, Sequencing, Microfluidics, Spectrometry, Microscopes, High content analysis and others. Continuous advancements in technologies significantly revealed the heterogeneity, which will further enhance the cell analysis application.
View Details
This pipeline analysis gives a comprehensive insights on the various emerging isotope based candidates being developed for the both diagnosis as well as treatment of various cancers and non-cancer indications.
View Details
IQ4I

Latest News

Pharmaceutical Excipients Global Market is estimated to be worth $15,439.6 million by 2029

Pharmaceutical excipients are inactive substances in the drug which help in modulating the solubility, bioavailability, and stability of active substances for formulating final drug dosage forms. The excipients form the major part of any medicinal product and the proportion of it, when compared to Active Phar...

continue reading

Active Pharmaceutical Ingredients (API) is estimated to be worth $388.0 billion by 2029

Each drug is made up of two components that are API and excipients, having curative activity. APIs are often known as bulk pharmaceuticals and most of all APIs are in powder form. Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is hav...

continue reading
IQ4I

Clientele

Offering solutions to >500 clients from the U.S., Europe, Japan, Korea, Singapore and Australia in realizing the market potential and competitive intelligence across healthcare domains (Medical Technologies, Pharmaceutical, Biotech and Life Sciences).

IQ4I

clients testimonials

  • Before finalizing IQ4I's report we have considered our options for various market reports, but all the reports lack in some or the other part, which is quite crucial for our business. We are looking for information sources that can help us triangulate data that we collect on our own. IQ4I report intrigues me and my team enough that we had further explored by requesting a customized sample. Information what Iq4I provided was almost matching with our research.

  • IQ4I helped us in geographic based mapping of Pharmaceutical & biotech companies, academic institutes and spin-offs, healthcare providers focusing to develop innovative solutions to global healthcare problems. They understood our partnering areas of interest very well and provided a detailed presentation. Good job!!

  • Our association started with a small pilot project and now they are providing us drug pipeline reports on regular basis. The best thing about IQ4I reports is that we can ask for customization and they cover all treatment modalities. IQ4I is highly flexible and approachable.

  • We are really happy with the content and quality of the report. Thank you for your support and the customization on this report. We will be using this report for a variety of our public communications.

  • We believe our hunt for a consulting firm ends here, which understands the discovery outsourcing market thoroughly. Their insights on competitive intelligence were of great help to us.

  • These numbers are clearly far more accurate as they are very close to the numbers we have in our analysis based on populations. This makes them valuable and immediately useful.